Neuroendocrine abnormalities in depressive illness
Brambilla, F.; Smeraldi, E.; Sacchetti, E.; Bellodi, L.; Genazzani, A.R.; Facchinetti, F.; Müller, E.E.
Advances in Biochemical Psychopharmacology 32: 329-340
1982
ISSN/ISBN: 0065-2229 PMID: 6283809 Document Number: 195735
Document emailed within 1 workday
Related Documents
Targum, S.D. 1983: The application of serial neuroendocrine challenge studies in the management of depressive disorder Biological Psychiatry 18(1): 3-19Robertson, A.G.; Tricou, B.J.; Fang, V.S.; Meltzer, H.Y. 1982: Biological markers for depressive illness Psychopharmacology Bulletin 18(4): 120-122
Kramer, B.A.; Katz, J.L. 1978: Circadian temperature variation and depressive illness Journal of Clinical Psychiatry 39(5): 439-444
Kestenbaum, C.J. 1980: Adolescents at risk for manic-depressive illness Adolescent Psychiatry 8: 344-366
Fuchs, C.Z.; Himmelhoch, J.M. 1980: Pseudomanic-depressive illness and cognitive-behavior therapy Journal of Nervous and Mental Disease 168(6): 382-384
Akiskal, H.S. 1982: Factors associated with incomplete recovery in primary depressive illness Journal of Clinical Psychiatry 43(7): 266-271
Horowitz, H.A. 1977: Lithium and the treatment of adolescent manic depressive illness Diseases of the Nervous System 38(6): 480-483
Deva, M.P. 2006: Depressive illness--the need for a paradigm shift in its understanding and management Medical Journal of Malaysia 61(1): 4-6
Herridge, C.F.; Low-Beer, L.; Marsh, B.D. 1973: The use of dothiepin in long-term treatment of depressive illness Activitas Nervosa Superior 15(2): 87-88
Chen, L.; Liu, H.; Chen, J.-l.; Gao, X.-x.; Zhou, Y.-z.; Tian, J.-s.; Qin, X.-m. 2015: Anti-depressive mechanism of Fufang Chaigui prescription based on neuroendocrine hormone and metabolomic correlation analysis Zhongguo Zhong Yao Za Zhi 40(20): 4080-4087
Feely, M. 1992: A strategy to regain control: helplessness and depressive illness in women Professional Nurse 8(2): 113-117
Lehrer, S.; Brown, R.R.; Lee, C.; Kalnicki, S.; Lipsztein, R.; Bloomer, W.D. 1988: Neuroendocrine abnormalities and the pathogenesis of estrogen-receptor-positive breast cancer Mount Sinai Journal of Medicine new York 55(4): 272-275
Cosyns, P. 1974: A single daily dose of a sustained release form of amitriptyline in depressive illness Acta Psychiatrica Belgica 74(4): 430-436
1988: The course and treatment of manic-depressive illness: an update. May 31, 1988, Key Biscayne, Florida. Proceedings Journal of Clinical Psychiatry 49 Suppl: 1-26
Turkson, S.N.; Dua, A.N. 1996: A study of the social and clinical characteristics of depressive illness among Ghanaian women--(1988-1992) West African Journal of Medicine 15(2): 85-90
Lennox, I.G.; Asbury, J.F.; Couldrick, W.G.; Beswick, K.B. 1978: Viloxazine and amitriptyline in depressive illness. a double blind controlled trial in general practice Practitioner 220(1315): 153-156
Mehmedika-Suljić, E. 2008: Presence of depressive disorder among patients with epilepsy in relation to the duration of illness and type of antiepileptic therapy Medicinski Arhiv 62(3): 156-158
Sachs, F.L.; Landsberg, L.; Brooten, P. 1970: Medical Grand Rounds, Yale-New Haven Hospital. a case of manic-depressive illness with lithium toxicity Connecticut Medicine 34(1): 36-39
Whitehead, A.M.; Ashford, J.J. 1992: Fluvoxamine in the treatment of depressive illness. a series of double-blind hospital based comparative studies carried out in the UK British Journal of Clinical Practice 46(1): 21-23
Leboyer, M.; Feingold, J.; des Lauriers, A. 1991: Hereditary factors in manic-depressive disease. Search for determinant genetic abnormalities, probably multiple and complex La Revue du Praticien 41(24): 2473-2475